Treatment-related myelodysplastic syndrome after temozolomide use in a child: First report

Christelle Dufour; Lydie Da Costa; Nathalie Auger; Marc Jullien; Ranjeev Bhangoo; Jacques Grill

doi:10.1097/MPH.0b013e318182e74f

Treatment-related myelodysplastic syndrome after temozolomide use in a child: First report

Christelle Dufour, Lydie Da Costa, Nathalie Auger, Marc Jullien, Ranjeev Bhangoo, Jacques Grill

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

14 Citations (Scopus)

Résumé

Temozolomide is an effective alkylating agent that is increasingly used for the treatment of pediatric brain tumors. Secondary, or treatment-related, myelodysplasia is a life-threatening complication of alkylating chemotherapy and has been reported in children with brain tumors after treatments other than temozolomide. We describe for the first time a case of temozolomide-related myelodysplasia in a child.

langue originale	Anglais
Pages (de - à)	857-859
Nombre de pages	3
journal	Journal of Pediatric Hematology/Oncology
Volume	30
Numéro de publication	11
Les DOIs	https://doi.org/10.1097/MPH.0b013e318182e74f
état	Publié - 1 nov. 2008

Accès au document

10.1097/MPH.0b013e318182e74f

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{1e2ed6d32486440295987c8141ddddf9,

title = "Treatment-related myelodysplastic syndrome after temozolomide use in a child: First report",

abstract = "Temozolomide is an effective alkylating agent that is increasingly used for the treatment of pediatric brain tumors. Secondary, or treatment-related, myelodysplasia is a life-threatening complication of alkylating chemotherapy and has been reported in children with brain tumors after treatments other than temozolomide. We describe for the first time a case of temozolomide-related myelodysplasia in a child.",

keywords = "Brain tumor, Child, Temozolomide, Treatment-related myelodysplasia",

author = "Christelle Dufour and Costa, {Lydie Da} and Nathalie Auger and Marc Jullien and Ranjeev Bhangoo and Jacques Grill",

year = "2008",

month = nov,

day = "1",

doi = "10.1097/MPH.0b013e318182e74f",

language = "English",

volume = "30",

pages = "857--859",

journal = "Journal of Pediatric Hematology/Oncology",

issn = "1077-4114",

number = "11",

}

TY - JOUR

T1 - Treatment-related myelodysplastic syndrome after temozolomide use in a child

T2 - First report

AU - Dufour, Christelle

AU - Costa, Lydie Da

AU - Auger, Nathalie

AU - Jullien, Marc

AU - Bhangoo, Ranjeev

AU - Grill, Jacques

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Temozolomide is an effective alkylating agent that is increasingly used for the treatment of pediatric brain tumors. Secondary, or treatment-related, myelodysplasia is a life-threatening complication of alkylating chemotherapy and has been reported in children with brain tumors after treatments other than temozolomide. We describe for the first time a case of temozolomide-related myelodysplasia in a child.

AB - Temozolomide is an effective alkylating agent that is increasingly used for the treatment of pediatric brain tumors. Secondary, or treatment-related, myelodysplasia is a life-threatening complication of alkylating chemotherapy and has been reported in children with brain tumors after treatments other than temozolomide. We describe for the first time a case of temozolomide-related myelodysplasia in a child.

KW - Brain tumor

KW - Child

KW - Temozolomide

KW - Treatment-related myelodysplasia

UR - http://www.scopus.com/inward/record.url?scp=58149147634&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e318182e74f

DO - 10.1097/MPH.0b013e318182e74f

M3 - Article

C2 - 18989164

AN - SCOPUS:58149147634

SN - 1077-4114

VL - 30

SP - 857

EP - 859

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

IS - 11

ER -